{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:47:00Z","timestamp":1791737220121,"version":"4.3.4"},"reference-count":27,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"University of South Africa","id":[{"id":"https:\/\/ror.org\/048cwvf49","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biopharmaceutical Statistics"],"DOI":"10.1080\/10543406.2026.2741426","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:22:30Z","timestamp":1791735750000},"page":"1-22","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The power prior for zero-inflated count models: Analysis based on episodes of urinary incontinence"],"prefix":"10.1080","author":[{"given":"Akalu Banbeta","family":"Tereda","sequence":"first","affiliation":[{"name":"University of South Africa (UNISA)","place":["Johannesburg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Legesse Kassa","family":"Debusho","sequence":"additional","affiliation":[{"name":"University of South Africa (UNISA)","place":["Johannesburg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2023.2190933"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2178"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8019"},{"issue":"298","key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/01621459.1962.10480660","article-title":"On the foundations of statistical inference","volume":"57","author":"Birnbaum A","year":"1996","unstructured":"Birnbaum A. 1996. On the foundations of statistical inference. J Am Stat Assoc. 57(298):269\u2013306.","journal-title":"J Am Stat Assoc"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/10618600.1998.10474787"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/env.752"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1467-9868.2007.00650.x","article-title":"Marginal likelihood estimation via power posteriors","volume":"80","author":"Friel N","year":"2008","unstructured":"Friel N, Pettitt A. 2008. Marginal likelihood estimation via power posteriors. J R Stat Soc: Ser B (Stat Methodol. 80:589\u2013607.","journal-title":"J R Stat Soc: Ser B (Stat Methodol"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1214\/ss\/1028905934"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1993.10476353"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198522669.003.0010"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201700246"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5851"},{"issue":"2","key":"e_1_3_4_14_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.urology.2013.02.077","article-title":"A phase iii, randomized, double-blind, parallel-group, placebo-conrolled, multicentre study to assess the efficacy and safety of the adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder","volume":"82","author":"Herschorn S","year":"2013","unstructured":"Herschorn S et al. 2013. A phase iii, randomized, double-blind, parallel-group, placebo-conrolled, multicentre study to assess the efficacy and safety of the adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder. Urology. 82(2):313\u2013320.","journal-title":"Urology"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1541-0420.2011.01564.x"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1214\/12-BA722"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1214\/ss\/1009212673"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6728"},{"issue":"2","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2012.10.016","article-title":"Efficacy and tolerability of mirabegron, a beta(3)- adrenoceptor agonist, in patients with overactive bladder: results from a randomized european-australian phase 3 trial","volume":"60","author":"Khullar VA","year":"2013","unstructured":"Khullar VA et al. 2013. Efficacy and tolerability of mirabegron, a beta(3)- adrenoceptor agonist, in patients with overactive bladder: results from a randomized european-australian phase 3 trial. Eur Urology. 60(2):283\u2013295.","journal-title":"Eur Urology"},{"issue":"1","key":"e_1_3_4_20_1","first-page":"1","article-title":"A review of dynamic borrowing methods with applications in pharmaceutical research Brazilian journal of probability and statistics","volume":"38","author":"Lesaffre E","year":"2024","unstructured":"Lesaffre E, Qi H, Banbeta A, van Rosmalen J. 2024. A review of dynamic borrowing methods with applications in pharmaceutical research Brazilian journal of probability and statistics. J Validation Technol. 38(1):1\u201331.","journal-title":"J Validation Technol"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.782"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.1664"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.1722"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774509356002"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.10.017"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(76)90044-8"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12242"},{"key":"e_1_3_4_28_1","doi-asserted-by":"crossref","DOI":"10.1177\/0962280217694506","article-title":"Including historical data in the analysis of clinical trials: Is it worth the effort?","author":"van Rosmalen J","year":"2018","unstructured":"van Rosmalen J, Dejardin D, van Norden Y, L\u00f6wenberg B, Lesaffre E. 2018. Including historical data in the analysis of clinical trials: Is it worth the effort? Statistical Methods in Medical Research. 27(10):3167\u20133182.","journal-title":"Statistical Methods in Medical Research"}],"container-title":["Journal of Biopharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10543406.2026.2741426","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10543406.2026.2741426","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10543406.2026.2741426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:22:32Z","timestamp":1791735752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10543406.2026.2741426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,11]]},"references-count":27,"alternative-id":["10.1080\/10543406.2026.2741426"],"URL":"https:\/\/doi.org\/10.1080\/10543406.2026.2741426","relation":{},"ISSN":["1054-3406","1520-5711"],"issn-type":[{"value":"1054-3406","type":"print"},{"value":"1520-5711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}